Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Expression of inhibitory regulators of innate immunity in patients with active tuberculosis.

Blok DC, Kager LM, Hoogendijk AJ, Lede IO, Rahman W, Afroz R, Bresser P, van der Zee JS, Ghose A, Visser CE, de Jong MD, Zahed AS, Husain MA, Alam KM, Barua PC, Hassan M, Hossain A, Tayab MA, Lutter R, Day N, Dondorp AM, de Vos AF, van 't Veer C, van der Poll T.

BMC Infect Dis. 2015 Feb 26;15:98. doi: 10.1186/s12879-015-0833-z.

2.

Impaired toll like receptor 9 response in pulmonary tuberculosis.

Ramakrishna K, Premkumar K, Kabeerdoss J, John KR.

Cytokine. 2017 Feb;90:38-43. doi: 10.1016/j.cyto.2016.10.006. Epub 2016 Oct 18.

PMID:
27768958
3.

[Frontier of mycobacterium research--host vs. mycobacterium].

Okada M, Shirakawa T.

Kekkaku. 2005 Sep;80(9):613-29. Japanese.

PMID:
16245793
4.

SOCS1 gene expression is increased in severe pulmonary tuberculosis.

Masood KI, Rottenberg ME, Carow B, Rao N, Ashraf M, Hussain R, Hasan Z.

Scand J Immunol. 2012 Oct;76(4):398-404. doi: 10.1111/j.1365-3083.2012.02731.x.

5.

Interleukin 1-Beta (IL-1β) Production by Innate Cells Following TLR Stimulation Correlates With TB Recurrence in ART-Treated HIV-Infected Patients.

Thobakgale C, Naidoo K, McKinnon LR, Werner L, Samsunder N, Karim SA, Ndungʼu T, Altfeld M, Naidoo K.

J Acquir Immune Defic Syndr. 2017 Feb 1;74(2):213-220. doi: 10.1097/QAI.0000000000001181.

6.

Expression of M. tuberculosis-induced suppressor of cytokine signaling (SOCS) 1, SOCS3, FoxP3 and secretion of IL-6 associates with differing clinical severity of tuberculosis.

Masood KI, Rottenberg ME, Salahuddin N, Irfan M, Rao N, Carow B, Islam M, Hussain R, Hasan Z.

BMC Infect Dis. 2013 Jan 15;13:13. doi: 10.1186/1471-2334-13-13.

7.

Differential expression of Toll-like receptors on human alveolar macrophages and autologous peripheral monocytes.

Juarez E, Nuñez C, Sada E, Ellner JJ, Schwander SK, Torres M.

Respir Res. 2010 Jan 5;11:2. doi: 10.1186/1465-9921-11-2.

8.

Toll-like receptor 1 variations influence susceptibility and immune response to Mycobacterium tuberculosis.

Dittrich N, Berrocal-Almanza LC, Thada S, Goyal S, Slevogt H, Sumanlatha G, Hussain A, Sur S, Burkert S, Oh DY, Valluri V, Schumann RR, Conrad ML.

Tuberculosis (Edinb). 2015 May;95(3):328-35. doi: 10.1016/j.tube.2015.02.045. Epub 2015 Feb 28.

PMID:
25857934
9.

Decreased IL-17 during treatment of sputum smear-positive pulmonary tuberculosis due to increased regulatory T cells and IL-10.

Xu L, Cui G, Jia H, Zhu Y, Ding Y, Chen J, Lu C, Ye P, Gao H, Li L, Ma W, Lyu J, Diao H.

J Transl Med. 2016 Jun 16;14(1):179. doi: 10.1186/s12967-016-0909-6.

10.

HIV-tuberculosis-associated immune reconstitution inflammatory syndrome is characterized by Toll-like receptor and inflammasome signalling.

Lai RPJ, Meintjes G, Wilkinson KA, Graham CM, Marais S, Van der Plas H, Deffur A, Schutz C, Bloom C, Munagala I, Anguiano E, Goliath R, Maartens G, Banchereau J, Chaussabel D, O'Garra A, Wilkinson RJ.

Nat Commun. 2015 Sep 24;6:8451. doi: 10.1038/ncomms9451.

11.

Enhanced expression of TNF-α type-1 receptors by immune cells in active pulmonary tuberculosis.

Alshevskaya AA, Kireev FD, Laushkina ZA, Lopatnikova JA, Gladkikh VS, Sennikova JA, Karaulov AV, Sennikov SV.

Int J Tuberc Lung Dis. 2018 Feb 1;22(2):212-220. doi: 10.5588/ijtld.17.0404.

PMID:
29506619
12.

Cytokine gene expression in intestinal tuberculosis and Crohn's disease.

Pugazhendhi S, Jayakanthan K, Pulimood AB, Ramakrishna BS.

Int J Tuberc Lung Dis. 2013 May;17(5):662-8. doi: 10.5588/ijtld.12.0600.

PMID:
23575333
13.

Compartmentalized bronchoalveolar IFN-gamma and IL-12 response in human pulmonary tuberculosis.

Herrera MT, Torres M, Nevels D, Perez-Redondo CN, Ellner JJ, Sada E, Schwander SK.

Tuberculosis (Edinb). 2009 Jan;89(1):38-47. doi: 10.1016/j.tube.2008.08.002. Epub 2008 Oct 9.

14.

Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment.

Sahiratmadja E, Alisjahbana B, de Boer T, Adnan I, Maya A, Danusantoso H, Nelwan RH, Marzuki S, van der Meer JW, van Crevel R, van de Vosse E, Ottenhoff TH.

Infect Immun. 2007 Feb;75(2):820-9. Epub 2006 Dec 4.

15.

Toll-like receptor 2 and DC-SIGNR1 differentially regulate suppressors of cytokine signaling 1 in dendritic cells during Mycobacterium tuberculosis infection.

Srivastava V, Manchanda M, Gupta S, Singla R, Behera D, Das G, Natarajan K.

J Biol Chem. 2009 Sep 18;284(38):25532-41. doi: 10.1074/jbc.M109.006221. Epub 2009 Jul 17.

16.

IL-37 Expression is Upregulated in Patients with Tuberculosis and Induces Macrophages Towards an M2-like Phenotype.

Huang Z, Gao C, Chi X, Hu YW, Zheng L, Zeng T, Wang Q.

Scand J Immunol. 2015 Oct;82(4):370-9. doi: 10.1111/sji.12326.

17.

Mycobacterium tuberculosis multi-drug-resistant strain M induces IL-17+ IFNγ- CD4+ T cell expansion through an IL-23 and TGF-β-dependent mechanism in patients with MDR-TB tuberculosis.

Basile JI, Kviatcovsky D, Romero MM, Balboa L, Monteserin J, Ritacco V, Lopez B, Sabio y García C, García A, Vescovo M, Montaner PG, Palmero D, Del Carmen Sasiain M, de la Barrera S.

Clin Exp Immunol. 2017 Jan;187(1):160-173. doi: 10.1111/cei.12873. Epub 2016 Nov 2.

18.

The pathogen recognition sensor, NOD2, is variably expressed in patients with pulmonary tuberculosis.

Lala S, Dheda K, Chang JS, Huggett JF, Kim LU, Johnson MA, Rook GA, Keshav S, Zumla A.

BMC Infect Dis. 2007 Aug 16;7:96.

19.

Systemic Immunological changes in patients with distinct clinical outcomes during Mycobacterium tuberculosis infection.

Morais-Papini TF, Coelho-Dos-Reis JGA, Wendling APB, do Vale Antonelli LR, Wowk PF, Bonato VLD, Augusto VM, Elói-Santos S, Martins-Filho OA, Carneiro CM, Teixeira-Carvalho A.

Immunobiology. 2017 Nov;222(11):1014-1024. doi: 10.1016/j.imbio.2017.05.016. Epub 2017 May 26.

PMID:
28619539
20.

IRAK-M alters the polarity of macrophages to facilitate the survival of Mycobacterium tuberculosis.

Shen P, Li Q, Ma J, Tian M, Hong F, Zhai X, Li J, Huang H, Shi C.

BMC Microbiol. 2017 Aug 23;17(1):185. doi: 10.1186/s12866-017-1095-2.

Supplemental Content

Support Center